For-Profit Plasma Clinics Under Fire After Decade of Safety Data
New data obtained by CBC News is raising serious questions about the safety of Canada's growing paid plasma donation industry — and the findings are stark.
According to records covering the past decade, nearly all serious adverse reactions among plasma donors in Canada occurred at for-profit donation sites. These incidents include cases where donors were left in life-threatening condition, required hospitalization, or needed other significant medical intervention after their donations.
What the Data Shows
The CBC investigation reveals a troubling pattern: while voluntary, non-profit plasma donation through Canadian Blood Services has a strong safety record, the commercial sector — which pays donors for their plasma — accounts for a disproportionate share of serious complications.
Serious adverse reactions can include severe fainting, cardiac events, nerve injuries, and other medical emergencies that go well beyond the minor dizziness or bruising that donors might typically expect.
The data raises questions about whether the financial incentive to donate — which can draw in repeat donors who may push their physical limits — contributes to higher rates of serious complications at commercial sites.
Canada's Paid Plasma Industry Has Grown Rapidly
Over the past several years, for-profit plasma collection companies have expanded their footprint across Canada, with clinics operating in major cities and smaller centres alike. These companies collect plasma that is used to manufacture life-saving medications, including treatments for immune disorders and bleeding conditions.
Proponents of paid plasma collection argue that donor compensation helps address chronic shortages of plasma-derived medicines and reduces Canada's dependence on imported plasma products — much of which already comes from paid donors in the United States.
But critics, including some health advocates and medical professionals, have long warned that paying donors creates perverse incentives that could compromise both donor safety and blood product quality.
Calls for Stronger Federal Oversight
The CBC findings are likely to intensify calls for tighter federal regulation of the paid plasma sector. Currently, Health Canada oversees plasma collection in the country, but critics say the regulatory framework hasn't kept pace with the industry's rapid growth.
Canadian Blood Services, which operates the voluntary system, has consistently maintained that a voluntary model is the safest and most ethical approach to blood and plasma collection — a position supported by the World Health Organization.
For donors considering plasma donation, health advocates recommend choosing regulated, reputable clinics and being transparent with staff about any health conditions or previous reactions.
What This Means for Canadians
Plasma-derived therapies are critical for thousands of Canadians living with conditions like primary immunodeficiency and hemophilia. Ensuring a safe, reliable supply — whether through voluntary or commercial means — is a genuine public health priority.
But the CBC data suggests that as Canada leans further into commercial plasma collection to meet that need, the safety of donors at for-profit sites deserves far more scrutiny than it has received.
Health Canada has not yet responded publicly to the findings.
Source: CBC News Top Stories. Original reporting by CBC News.
